Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2021 Volume 24 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2021 Volume 24 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Ginsenoside Rk1 protects human melanocytes from H2O2‑induced oxidative injury via regulation of the PI3K/AKT/Nrf2/HO‑1 pathway

  • Authors:
    • Jian Xiong
    • Jianing Yang
    • Kai Yan
    • Jing Guo
  • View Affiliations / Copyright

    Affiliations: Department of Dermatology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China, Department of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610072, P.R. China
    Copyright: © Xiong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 821
    |
    Published online on: September 24, 2021
       https://doi.org/10.3892/mmr.2021.12462
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Vitiligo is a cutaneous depigmentation disorder caused by melanocyte injury or aberrant functioning. Oxidative stress (OS) is considered to be a major cause of the onset and progression of vitiligo. Ginsenoside Rk1 (RK1), a major compound isolated from ginseng, has antioxidant activity. However, whether RK1 can protect melanocytes against oxidative injury remains unknown. The aim of the present study was to investigate the potential protective effect of RK1 against OS in the human PIG1 melanocyte cell line induced with hydrogen peroxide (H2O2), and to explore its underlying mechanism. PIG1 cells were pretreated with RK1 (0, 0.1, 0.2 and 0.4 mM) for 2 h followed by exposure to 1.0 mM H2O2 for 24 h. Cell viability and apoptosis were determined with Cell Counting Kit‑8 and flow cytometry assays, respectively. The activity levels of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH‑Px) were analyzed using ELISA kits. Protein expression levels, including Bax, caspase‑3, Bcl‑2, phosphorylated‑AKT, AKT, nuclear factor erythroid 2‑related factor 2 (Nrf2), heme oxygenase‑1 (HO‑1), cytosolic Nrf2 and nuclear Nrf2, were analyzed using western blot analysis. In addition, the expression and localization of Nrf2 were detected by immunofluorescence. RK1 treatment significantly improved cell viability, reduced the apoptotic rate and increased the activity levels of SOD, CAT and GSH‑Px in the PIG1 cell line exposed to H2O2. In addition, RK1 treatment notably induced Nrf2 nuclear translocation, increased the protein expression levels of Nrf2 and HO‑1, and the ratio of phosphorylated‑AKT to AKT in the PIG1 cells exposed to H2O2. Furthermore, LY294002 could reverse the protective effect of RK1 in melanocytes against oxidative injury. These data demonstrated that RK1 protected melanocytes from H2O2‑induced OS by regulating Nrf2/HO‑1 protein expression, which may provide evidence for the application of RK1 for the treatment of vitiligo.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Dey-Rao R and Sinha AA: Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo. Genes Immunity. 17:30–45. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Saleh MA, Mahran OM and Bassam Al-Salahy M: Circulating oxidative stress status in dromedary camels infested with sarcoptic mange. Vet Res Commun. 35:35–45. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Fatehi-Hassanabad Z, Chan CB and Furman BL: Reactive oxygen species and endothelial function in diabetes. Eur J Pharmacol. 636:8–17. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Shi Q, Zhang W, Guo S, Jian Z, Li S, Li K, Ge R, Dai W, Wang G, Gao T and Li C: Oxidative stress-induced overexpression of miR-25: The mechanism underlying the degeneration of melanocytes in vitiligo. Cell Death Differ. 23:496–508. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Guo S and Zhang Q: Paeonol protects melanocytes against hydrogen peroxide-induced oxidative stress through activation of Nrf2 signaling pathway. Drug Dev Res. Jan 24–2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

6 

Zhuang T, Li S, Yi X, Guo S, Wang Y, Chen J, Liu L, Jian Z, Gao T, Kang P and Li C: Tranilast directly targets NLRP3 to protect melanocytes from keratinocyte-derived IL-1β under oxidative stress. Front Cell Dev Biol. 8:5882020. View Article : Google Scholar : PubMed/NCBI

7 

Yang L, Yang F, Teng L and Katayama I: 6-shogaol protects human melanocytes against oxidative stress through activation of the Nrf2-antioxidant response element signaling pathway. Int J Mol Sci. 21:35372020. View Article : Google Scholar : PubMed/NCBI

8 

Ma J, Li S, Zhu L, Guo S, Yi X, Cui T, He Y, Chang Y, Liu B, Li C and Jian Z: Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway. Free Radic Biolo Med. 129:492–503. 2018. View Article : Google Scholar : PubMed/NCBI

9 

Li XS, Tang XY, Su W and Li X: Vitexin protects melanocytes from oxidative stress via activating MAPK-Nrf2/ARE pathway. Immunopharmacol Immunotoxicol. 42:594–603. 2020. View Article : Google Scholar : PubMed/NCBI

10 

Qiao Z, Xu Z, Xiao Q, Yang Y, Ying J, Xiang L and Zhang C: Dysfunction of ATG7-dependent autophagy dysregulates the antioxidant response and contributes to oxidative stress-induced biological impairments in human epidermal melanocytes. Cell Death Discov. 6:312020. View Article : Google Scholar : PubMed/NCBI

11 

Hu Y, Huang J, Li Y, Jiang L, Ouyang Y, Li Y, Yang L, Zhao X, Huang L, Xiang H, et al: Cistanche deserticola polysaccharide induces melanogenesis in melanocytes and reduces oxidative stress via activating NRF2/HO-1 pathway. J Cell Mol Med. 24:4023–4035. 2020. View Article : Google Scholar : PubMed/NCBI

12 

Choi SJ and Kim HS: Deregulation of Nrf2/ARE signaling pathway causes susceptibility of dystrophin-deficient myotubes to menadione-induced oxidative stress. Exp Cell Res. 364:224–233. 2018. View Article : Google Scholar : PubMed/NCBI

13 

Ramprasath T, Vasudevan V, Sasikumar S, Puhari SS, Saso L and Selvam GS: Regression of oxidative stress by targeting eNOS and Nrf2/ARE signaling: A guided drug target for cardiovascular diseases. Curr Top Med Chem. 15:857–871. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Ndisang J: Synergistic interaction between heme oxygenase (HO) and nuclear-factor E2-related factor-2 (Nrf2) against oxidative stress in cardiovascular related diseases. Curr Pharm Design. 23:1465–1470. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Lin CC, Hsiao LD, Cho RL and Yang CM: CO-releasing molecule-2 induces Nrf2/ARE-dependent heme oxygenase-1 expression suppressing TNF-α-induced pulmonary inflammation. J Clin Med. 8:4362019. View Article : Google Scholar : PubMed/NCBI

16 

Chen S, Li X, Wang Y, Mu P, Chen C, Huang P and Liu D: Ginsenoside Rb1 attenuates intestinal ischemia/reperfusioninduced inflammation and oxidative stress via activation of the PI3K/Akt/Nrf2 signaling pathway. Mol Med Rep. 19:3633–3641. 2019.PubMed/NCBI

17 

Shen R, Laval S, Cao X and Yu B: Synthesis of Δ 20-ginsenosides Rh4, (20E)-Rh3, Rg6, and Rk1: A general approach to access dehydrated ginsenosides. J Org Chem. 83:2601–2610. 2018. View Article : Google Scholar : PubMed/NCBI

18 

Kim JE, Lee W, Yang S, Cho SH, Baek MC, Song GY and Bae JS: Suppressive effects of rare ginsenosides, Rk1 and Rg5, on HMGB1-mediated septic responses. Food Chem Toxicol. 124:45–53. 2019. View Article : Google Scholar : PubMed/NCBI

19 

Wang W, Wang S, Liu J, Cai E, Zhu H, He Z, Gao Y, Li P and Zhao Y: Sesquiterpenoids from the root of Panax Ginseng protect CCl4-induced acute liver injury by anti-inflammatory and anti-oxidative capabilities in mice. Biomed Pharmacother. 102:412–419. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Qi ZL, Wang Z, Li W, Hou JG, Liu Y, Li XD, Li HP and Wang YP: Nephroprotective effects of anthocyanin from the fruits of Panax ginseng (GFA) on cisplatin-induced acute kidney injury in mice. Phytother Res. 31:1400–1409. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Yang CC, Chen CY, Wu CC, Koo M, Yu ZR and Wang BJ: Panax ginseng fraction F3 extracted by supercritical carbon dioxide protects against oxidative stress in ARPE-19 CElls. Int J Mol Sci. 17:17172016. View Article : Google Scholar : PubMed/NCBI

22 

Shen W, Wei Y, Tang D, Jia X and Chen B: Metabolite profiles of ginsenosides Rk1 and Rg5 in zebrafish using ultraperformance liquid chromatography/quadrupole-time-of-flight MS. J Ginseng Res. 41:78–84. 2017. View Article : Google Scholar : PubMed/NCBI

23 

Hu JN, Xu XY, Li W, Wang YM, Liu Y, Wang Z and Wang YP: Ginsenoside Rk1 ameliorates paracetamol-induced hepatotoxicity in mice through inhibition of inflammation, oxidative stress, nitrative stress and apoptosis. J Ginseng Res. 43:10–19. 2019. View Article : Google Scholar : PubMed/NCBI

24 

Chang Y, Li S, Guo W, Yang Y, Zhang W, Zhang Q, He Y, Yi X, Cui T, An Y, et al: Simvastatin protects human melanocytes from H2O2-induced oxidative stress by activating Nrf2. J Invest Dermatol. 137:1286–1296. 2017. View Article : Google Scholar : PubMed/NCBI

25 

Jiang W, Li S, Chen X, Zhang W, Chang Y, He Y, Zhang S, Su X, Gao T, Li C and Jian Z: Berberine protects immortalized line of human melanocytes from HO-induced oxidative stress via activation of Nrf2 and Mitf signaling pathway. J Dermatol Sci. 94:236–243. 2019. View Article : Google Scholar : PubMed/NCBI

26 

Yamamoto A, Yang L, Kuroda Y, Guo J, Teng L, Tsuruta D and Katayama I: Local epidermal endocrine estrogen protects human melanocytes against oxidative stress, a novel insight into vitiligo pathology. Int J Mol Sci. 22:2692020. View Article : Google Scholar : PubMed/NCBI

27 

Shalbaf M, Gibbons NC, Wood JM, Maitland DJ, Rokos H, Elwary SM, Marles LK and Schallreuter KU: Presence of epidermal allantoin further supports oxidative stress in vitiligo. Exp Dermatol. 17:761–770. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Becatti M: Oxidative stress and high-mobility group box 1 (HMGB1) protein release in vitiligo. Br J Dermatol. 176:1436–1437. 2017. View Article : Google Scholar : PubMed/NCBI

29 

Cui T, Zhang W, Li S, Chen X, Chang Y, Yi X, Kang P, Yang Y, Chen J, Liu L, et al: Oxidative stress-induced HMGB1 release from melanocytes: A paracrine mechanism underlying the cutaneous inflammation in vitiligo. J Invest Dermatol. 139:2174–2184.e4. 2019. View Article : Google Scholar : PubMed/NCBI

30 

Ahn S, Siddiqi MH, Aceituno VC, Simu SY, Zhang J, Jimenez Perez ZE, Kim YJ and Yang DC: Ginsenoside Rg5: Rk1 attenuates TNF-α/IFN-γ-induced production of thymus- and activation-regulated chemokine (TARC/CCL17) and LPS-induced NO production via downregulation of NF-κB/p38 MAPK/STAT1 signaling in human keratinocytes and macrophages. In Vitro Cell Dev Biol Anim. 52:287–295. 2016. View Article : Google Scholar : PubMed/NCBI

31 

Hong Y and Fan D: Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells. Toxicology. 418:22–31. 2019. View Article : Google Scholar : PubMed/NCBI

32 

Tulic MK, Cavazza E, Cheli Y, Jacquel A, Luci C, Cardot-Leccia N, Hadhiri-Bzioueche H, Abbe P, Gesson M, Sormani L, et al: Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo. Nat Commun. 10:21782019. View Article : Google Scholar : PubMed/NCBI

33 

Zhou J, An X, Dong J, Wang Y, Zhong H, Duan L, Ling J, Ping F and Shang J: IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo. FASEB J. 32:4899–4916. 2018. View Article : Google Scholar : PubMed/NCBI

34 

Haasler L, Kondadi AK, Tsigaras T, von Montfort C, Graf P, Stahl W and Brenneisen P: The BH3 mimetic (±) gossypol induces ROS-independent apoptosis and mitochondrial dysfunction in human A375 melanoma cells in vitro. Arch Toxicol. 95:1349–1365. 2021. View Article : Google Scholar : PubMed/NCBI

35 

Tang L, Li J, Fu W, Wu W and Xu J: Suppression of FADS1 induces ROS generation, cell cycle arrest, and apoptosis in melanocytes: Implications for vitiligo. Aging (Albany NY). 11:11829–11843. 2019. View Article : Google Scholar : PubMed/NCBI

36 

Liang P, Xing X, Wu J, Song J and Liu Q: PM2.5 promotes apoptosis of human epidermal melanocytes through promoting oxidative damage and autophagy. Gen Physiol Biophys. 39:569–577. 2020. View Article : Google Scholar : PubMed/NCBI

37 

Li L, Yang J, Wang J and Kopeček J: Drug-free macromolecular therapeutics induce apoptosis via calcium influx and mitochondrial signaling pathway. Macromol Biosci. Jan 18–2018.(Epub ahead of print). doi: 10.1002/mabi.201700196.

38 

Gashegu J, Ladha R, Vanmuylder N, Philippson C, Bremer F, Rooze M and Louryan S: HSP110, caspase-3 and −9 expression in physiological apoptosis and apoptosis induced by in vivo embryonic exposition to all-trans retinoic acid or irradiation during early mouse eye development. J Anat. 210:532–541. 2007. View Article : Google Scholar : PubMed/NCBI

39 

Lu W, Zhao Y, Kong Y, Zhang W, Ma W, Li W and Wang K: Geniposide prevents H2O2-induced oxidative damage in melanocytes by activating the PI3K-Akt signalling pathway. Clin Exp Dermatol. 43:667–674. 2018. View Article : Google Scholar : PubMed/NCBI

40 

Ko H and Kim M: HO promotes the aging process of melanogenesis through modulation of MITF and Nrf2. Mol Biol Rep. 46:2461–2471. 2019. View Article : Google Scholar : PubMed/NCBI

41 

Jian Z, Tang L, Yi X, Liu B, Zhang Q, Zhu G, Wang G, Gao T and Li C: Aspirin induces Nrf2-mediated transcriptional activation of haem oxygenase-1 in protection of human melanocytes from H2 O2-induced oxidative stress. J Cell Mol Med. 20:1307–1318. 2016. View Article : Google Scholar : PubMed/NCBI

42 

Fan X and Wu X: MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway. J BUON. 24:273–279. 2019.PubMed/NCBI

43 

Kim H, Park CS and Lee AY: Reduced Nrf2 activation in PI3K phosphorylation-impaired vitiliginous keratinocytes increases susceptibility to ROS-generating chemical-induced apoptosis. Environ Toxicol. 32:2481–2491. 2017. View Article : Google Scholar : PubMed/NCBI

44 

Sugimoto M, Ko R, Goshima H, Koike A, Shibano M and Fujimori K: Formononetin attenuates H2O2-induced cell death through decreasing ROS level by PI3K/Akt-Nrf2-activated antioxidant gene expression and suppressing MAPK-regulated apoptosis in neuronal SH-SY5Y cells. Neurotoxicology. 85:186–200. 2021. View Article : Google Scholar : PubMed/NCBI

45 

Li Y, Guo Y, Feng Z, Bergan R, Li B, Qin Y, Zhao L, Zhang Z and Shi M: Involvement of the PI3K/Akt/Nrf2 signaling pathway in resveratrol-mediated reversal of drug resistance in HL-60/ADR cells. Nutr Cancer. 71:1007–1018. 2019. View Article : Google Scholar : PubMed/NCBI

46 

Zhou J, Ling J, Song J, Wang Y, Feng B and Ping F: Interleukin 10 protects primary melanocyte by activation of Stat-3 and PI3K/Akt/NF-κB signaling pathways. Cytokine. 83:275–281. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xiong J, Yang J, Yan K and Guo J: Ginsenoside Rk1 protects human melanocytes from H<sub>2</sub>O<sub>2</sub>‑induced oxidative injury via regulation of the PI3K/AKT/Nrf2/HO‑1 pathway. Mol Med Rep 24: 821, 2021.
APA
Xiong, J., Yang, J., Yan, K., & Guo, J. (2021). Ginsenoside Rk1 protects human melanocytes from H<sub>2</sub>O<sub>2</sub>‑induced oxidative injury via regulation of the PI3K/AKT/Nrf2/HO‑1 pathway. Molecular Medicine Reports, 24, 821. https://doi.org/10.3892/mmr.2021.12462
MLA
Xiong, J., Yang, J., Yan, K., Guo, J."Ginsenoside Rk1 protects human melanocytes from H<sub>2</sub>O<sub>2</sub>‑induced oxidative injury via regulation of the PI3K/AKT/Nrf2/HO‑1 pathway". Molecular Medicine Reports 24.5 (2021): 821.
Chicago
Xiong, J., Yang, J., Yan, K., Guo, J."Ginsenoside Rk1 protects human melanocytes from H<sub>2</sub>O<sub>2</sub>‑induced oxidative injury via regulation of the PI3K/AKT/Nrf2/HO‑1 pathway". Molecular Medicine Reports 24, no. 5 (2021): 821. https://doi.org/10.3892/mmr.2021.12462
Copy and paste a formatted citation
x
Spandidos Publications style
Xiong J, Yang J, Yan K and Guo J: Ginsenoside Rk1 protects human melanocytes from H<sub>2</sub>O<sub>2</sub>‑induced oxidative injury via regulation of the PI3K/AKT/Nrf2/HO‑1 pathway. Mol Med Rep 24: 821, 2021.
APA
Xiong, J., Yang, J., Yan, K., & Guo, J. (2021). Ginsenoside Rk1 protects human melanocytes from H<sub>2</sub>O<sub>2</sub>‑induced oxidative injury via regulation of the PI3K/AKT/Nrf2/HO‑1 pathway. Molecular Medicine Reports, 24, 821. https://doi.org/10.3892/mmr.2021.12462
MLA
Xiong, J., Yang, J., Yan, K., Guo, J."Ginsenoside Rk1 protects human melanocytes from H<sub>2</sub>O<sub>2</sub>‑induced oxidative injury via regulation of the PI3K/AKT/Nrf2/HO‑1 pathway". Molecular Medicine Reports 24.5 (2021): 821.
Chicago
Xiong, J., Yang, J., Yan, K., Guo, J."Ginsenoside Rk1 protects human melanocytes from H<sub>2</sub>O<sub>2</sub>‑induced oxidative injury via regulation of the PI3K/AKT/Nrf2/HO‑1 pathway". Molecular Medicine Reports 24, no. 5 (2021): 821. https://doi.org/10.3892/mmr.2021.12462
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team